PharmTech Drug Digest 11.20
News|Articles|April 7, 2005

HHS Awards $97-Million Vaccine Development Contract

HHS Awards $97-Million Vaccine Development Contract

The US Health and Human Services Department (HHS) has awarded Sanofi Pasteur, the vaccines business of the Sanofi-Aventis Group (Lyon, France and Swiftwater, PA, en.sanofi-aventis.com/), a $97-million contract to accelerate the development of new cell-culture influenza vaccines in the United States.

The company’s cell-culture influenza vaccine program is based on the “Per.C6” cell-line technology of Crucell N.V., a Dutch biotechnology company. Cell culture is an emerging technology that eliminates the need to use chicken eggs for the production of influenza vaccine. Instead of eggs, the virus is grown on specially selected cell lines, a process that may cut the manufacturing time from four weeks to two or three weeks after the virus strain has been identified and could potentially lead to a more-predictable process.

The five-year agreement also will fund the design of a US-based licensed cell-culture vaccine manufacturing facility. Pasteur will deliver to HHS a feasibility plan for a production plant designed to supply as many as 300 million monovalent influenza vaccine doses per year. The award will not fund the construction of the facility.

–Maribel Rios


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.